← Leaderboards
Olusegun Isaac Alatise
Sloan-Kettering Inst Can Research
$2,073,530
Attributed
$5,711,910
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,095,001 · 6
By mechanism
UH3$2,258,511 · 1
R01$1,765,345 · 1
D43$892,358 · 1
UG3$767,076 · 1
P20$411,711 · 2
Top collaborators
- T Peter Kingham17 shared
- Mengmeng Du5 shared
- David Wishart4 shared
- Francisco Sanchez Vega2 shared
- Richard N Fedorak1 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- T Peter Kingham$2,940,023
- David B. Solit$21,393,031
- Mengmeng Du$2,352,665
- Deborah Schrag$8,079,366
- David Wishart$3,311,142
Others in their field
Other Emerging Leaders on “Incidence”
- Yunda Huang · Fred Hutchinson Cancer Center$53,742,512
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$49,703,204
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Julie Ake · National Institute Of Allergy And Infectious Diseases$39,792,120
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420
Research focus
IncidenceNigerianMalignant NeoplasmsNigeriaColorectal CancerCountryRisk FactorsDiagnosisScreeningColon Cancer PatientsInfrastructureMortalityResearch PersonnelCost EffectiveColorectal Cancer RiskHigh RiskIncomeProgramsBiobankProspectiveCollaborationsBaseMemorial Sloan-Kettering Cancer CenterWorld Health Organization
Grant awards (17)
Admin-Core-001$28,620
P20 · FY2025 · CA
Addressing cancer disparities in Nigeria through Immuno-oncology Research â The NOLA Program$383,091
P20 · FY2024 · CA
Expanding cancer research capacity in Nigeria with team science$269,094
D43 · FY2024 · CA
Administrative supplement to expand cancer clinical trial capacity in sub-Saharan Africa$86,400
D43 · FY2024 · CA
Determining the risk factor profile and biology of colorectal cancer in Nigeria$349,720
R01 · FY2023 · CA
Expanding cancer research capacity in Nigeria with team science$268,073
D43 · FY2023 · CA
Point of care, real-time urine metabolomics test to diagnose colorectal cancers and polyps in low- and middle-income countries$740,348
UH3 · FY2022 · CA
Determining the risk factor profile and biology of colorectal cancer in Nigeria$355,560
R01 · FY2022 · CA
Expanding cancer research capacity in Nigeria with team science$268,791
D43 · FY2022 · CA
Collecting whole genome sequence data to enhance the value of the first multi-center study of colorectal cancer risk factors and biology in Nigeria$195,604
R01 · FY2022 · CA
Mentoring a Nigerian junior investigator with a mixed-methods analysis of barriers to colorectal cancer presentation in Nigeria$124,999
R01 · FY2022 · CA
Point of care, real-time urine metabolomics test to diagnose colorectal cancers and polyps in low- and middle-income countries$751,117
UH3 · FY2021 · CA
Determining the risk factor profile and biology of colorectal cancer in Nigeria$360,732
R01 · FY2021 · CA
Point of care, real-time urine metabolomics test to diagnose colorectal cancers and polyps in low- and middle-income countries$767,046
UH3 · FY2020 · CA
Determining the risk factor profile and biology of colorectal cancer in Nigeria$378,730
R01 · FY2020 · CA
Point of care, real-time urine metabolomics test to diagnose colorectal cancers and polyps in low- and middle-income countries$361,263
UG3 · FY2018 · EB
Point of care, real-time urine metabolomics test to diagnose colorectal cancers and polyps in low- and middle-income countries$405,813
UG3 · FY2017 · EB